Seizure Disorders
Seizure Disorders(癫痫症)
Seizure Disorders 相关产品(93)
- GC44842Riluzole-13C,15N2CAS: 1215552-03-6纯度: >98.00%
An internal standard for the quantification of riluzole
- GC45244(-)-(α)-Kainic Acid (hydrate)CAS: 58002-62-3纯度: >98.00%
An L-glutamate analog with neuroexcitatory activities
- GC45557Safinamide-d4CAS: 2748522-33-8纯度: >99.00%
An internal standard for the quantification of safinamide
- GC45721Stiripentol-d9CAS: 1185239-64-8纯度: >99.00%
An internal standard for the quantification of stiripentol
- GC45722Decanoic Acid-d3CAS: 102611-15-4纯度: >99.00%
An internal standard for the quantification of decanoic acid
- GC457732-chloro-N6-Cyclopentyladenosine (hydrate)CAS: 1217443-91-8纯度: >98.00%
A neuropeptide with diverse biological activities
- GC45802Zonisamide-13C2,15NCAS: 1188265-58-8纯度: >95.00%
An internal standard for the quantification of zonisamide
- GC45815Decanoic Acid-d19CAS: 88170-22-3纯度: >98.00%
An internal standard for the quantification of decanoic acid
- GC460091,2,3-Trioctanoyl-rac-glycerol-13C3CAS: 65402-55-3纯度: >95.00%
An internal standard for the quantification of 1,2,3-trioctanoyl glycerol- 13 C 3
- GC46127Decanoic Acid-d2CAS: 62716-49-8纯度: >99.00%
An internal standard for the quantification of decanoic acid
- GC46195Oxcarbazepine-d4CAS: 1134188-71-8纯度: >99.00%
An internal standard for the quantification of oxcarbazepine
- GC467155α,6β-Dihydroxycholestanol-d7CAS: 127684-07-5纯度: >99.00%
An internal standard for the quantification of 5α,6β-dihydroxycholestanol
- GC47315Ethosuximide-d5CAS: 1989660-59-4纯度: >99.00%
An internal standard for the quantification of ethosuximide
- GC47321Etifoxine-13C-d3CAS: 2738376-67-3纯度: >99.00%
A neuropeptide with diverse biological activities
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC44842 | Riluzole-13C,15N2 | 1215552-03-6 | >98.00% | |
An internal standard for the quantification of riluzole | ||||
| GC45045 | Thioperamide (maleate) | 148440-81-7 | >98.00% | |
A histamine H 3 receptor antagonist | ||||
| GC45137 | Valproic Acid Acyl-D-Glucuronide | - | >95.00% | |
A metabolite of valproic acid | ||||
| GC45244 | (-)-(α)-Kainic Acid (hydrate) | 58002-62-3 | >98.00% | |
An L-glutamate analog with neuroexcitatory activities | ||||
| GC45557 | Safinamide-d4 | 2748522-33-8 | >99.00% | |
An internal standard for the quantification of safinamide | ||||
| GC45698 | 1,2,3-Triheptanoyl-rac-glycerol | 620-67-7 | >99.00% | |
A triacylglycerol | ||||
| GC45721 | Stiripentol-d9 | 1185239-64-8 | >99.00% | |
An internal standard for the quantification of stiripentol | ||||
| GC45722 | Decanoic Acid-d3 | 102611-15-4 | >99.00% | |
An internal standard for the quantification of decanoic acid | ||||
| GC45773 | 2-chloro-N6-Cyclopentyladenosine (hydrate) | 1217443-91-8 | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC45802 | Zonisamide-13C2,15N | 1188265-58-8 | >95.00% | |
An internal standard for the quantification of zonisamide | ||||
| GC45815 | Decanoic Acid-d19 | 88170-22-3 | >98.00% | |
An internal standard for the quantification of decanoic acid | ||||
| GC45964 | (S)-3-N-Cbz-amino-succinimide | 60846-91-5 | >95.00% | |
An anticonvulsant | ||||
| GC45991 | NCS-382 (sodium salt) | 131733-92-1 | >95.00% | |
A GHB receptor antagonist | ||||
| GC46009 | 1,2,3-Trioctanoyl-rac-glycerol-13C3 | 65402-55-3 | >95.00% | |
An internal standard for the quantification of 1,2,3-trioctanoyl glycerol- 13 C 3 | ||||
| GC46083 | Adenylosuccinic Acid | 19046-78-7 | >95.00% | |
腺苷琥珀酸是一种嘌呤核苷酸，也是嘌呤核苷酸循环中的中间产物 | ||||
| GC46127 | Decanoic Acid-d2 | 62716-49-8 | >99.00% | |
An internal standard for the quantification of decanoic acid | ||||
| GC46195 | Oxcarbazepine-d4 | 1134188-71-8 | >99.00% | |
An internal standard for the quantification of oxcarbazepine | ||||
| GC46339 | (R)-4-Amino-3-hydroxybutyric Acid | 7013-07-2 | >95.00% | |
A GABA receptor modulator | ||||
| GC46505 | 2-(Isopentylamino)naphthalene-1,4-dione | 1607447-79-9 | >98.00% | |
A vitamin K analog | ||||
| GC46557 | 3,4-Dihydroquinolin-2(1H)-one | 553-03-7 | >98.00% | |
A building block | ||||
| GC46675 | 4-Phenyl-2-pyrrolidinone | 1198-97-6 | >98.00% | |
A precursor and synthetic intermediate | ||||
| GC46715 | 5α,6β-Dihydroxycholestanol-d7 | 127684-07-5 | >99.00% | |
An internal standard for the quantification of 5α,6β-dihydroxycholestanol | ||||
| GC47315 | Ethosuximide-d5 | 1989660-59-4 | >99.00% | |
An internal standard for the quantification of ethosuximide | ||||
| GC47321 | Etifoxine-13C-d3 | 2738376-67-3 | >99.00% | |
A neuropeptide with diverse biological activities | ||||